IBO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi impactbiomedinc.com
Impact BioMedical Inc (IBO) possesses moderate pricing power in the biosafety segment due to patents on plant-based compounds. The cash EBITDA trend clearly demonstrates current efficiency, with the metric reaching the level of 0.00. The Linebacker antiseptic line supports a network of licensees under FDA supervision, however, asset fragmentation and a rapid cash burn create significant financial risks.
Ringkesan rincian data analitis Impact BioMedical Inc (IBO)
- rega saiki lan proyeksi nilai saham:
- statistik kapitalisasi pasar:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Koefisien Total Utang marang Modal Impact BioMedical Inc|IBO - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas impactbiomedinc.com|IBO - Utang perusahaan|Rasio utang-utang marang kapitalisasi buku Impact BioMedical|IBO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Impact BioMedical|Indikator likuiditas cepet impactbiomedinc.com
- rincian bathi lan kelipatan pasar:
IBO - Penghasilan resik|Bathi resik mangsa ngarep Impact BioMedical Inc|IBO - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Impact BioMedical, Inc.|IBO - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Impact BioMedical|IBO - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Impact BioMedical|IBO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan impactbiomedinc.com|IBO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Impact BioMedical Inc
Analisis kabeh metrik perusahaan:Impact BioMedical, Inc., IBO
Integrating ESG standards into the management of biotechnological developments at Impact BioMedical Inc. (IBO) requires strict control over bioethics and safety costs. By analyzing the company's EBITDA, an investor assesses operating profit before depreciation and interest, which allows for the isolation of net cash flow from debt burdens and determines the actual efficiency of business scaling, confirming the asset's fundamental stability.
Karo sapa Impact BioMedical Inc saingan
Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HLN (Haleon Corp)|Kenvue Inc. - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi VRNA (veronapharma.com)|MENS: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Ligand Pharmaceuticals Incorporated (LGND)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Amneal Pharmaceuticals Inc|PRGO: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ALVO|Pendapatan operasional sadurunge ngurangi amortisasi liquidia.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Galapagos GLPG|ANIP - Bathi operasional sadurunge ngurangi amortisasi|MNKD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi AMPH|PCRX: Bathi operasional EBITDA|ars-pharma.com (SPRY) - Bathi operasional EBITDA|TBPH (Theravance Biopharma, Inc.) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Aquestive Therapeutics Inc (AQST)|Bathi operasional sadurunge ngurangi amortisasi SCPH (scPharmaceuticals Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TECX|Tonix Pharmaceuticals - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SXTC|Eupraxia Pharma - Bathi operasional EBITDA|BHST: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|EXOZ: Bathi operasional EBITDA|ORMP - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Entera Bio Ltd|Bathi sadurunge bunga, pajak, lan amortisasi ipatherapeutics.com HYFT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ABVC BioPharma, Inc. (ABVC)|Bathi operasional sadurunge ngurangi amortisasi Cumberland Pharmaceuticals Inc CPIX|Bathi operasional EBITDA QNTM (Quantum BioPharma Limited)|FibroGen Corporation (FGEN) - Bathi sadurunge bunga, pajak, lan amortisasi|Telomir Pharmaceuticals - Bathi operasional EBITDA|RANI (Rani Therapeutics) - Bathi operasional sadurunge amortisasi|SNYR: Bathi operasional EBITDA|RLYB - Pendapatan operasional sadurunge ngurangi amortisasi|LEXX (Lexaria Bioscience Corp) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Pulmatrix Corporation (PULM)|Bathi operasional EBITDA PTHL|Bathi operasional EBITDA aptorumgroup.com (APM)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lyra Therapeutics LYRA|TNF Pharmaceuticals Inc. - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|YCBD: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi PRFX (PainReform Corp)|CYTO: Bathi operasional EBITDA|LIPO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OptiNose|Bathi operasional sadurunge amortisasi PIRS (Pieris Pharmaceuticals Inc)|Bathi operasional EBITDA PROC|Bathi operasional sadurunge ngurangi amortisasi Petros Pharma PTPI|Bathi operasional EBITDA QLI (Qilian International)|Pendapatan operasional sadurunge ngurangi amortisasi acelyrin.com (SLRN)|TFF Pharmaceuticals, Inc. - Bathi operasional EBITDA
